EP0914041A4 - METHODS AND COMPOSITIONS FOR SUPPRESSING AN IMMUNE RESPONSE USING CLASS II PEPTIDES OF THE MAJOR HISTOCOMPATIBILITY COMPLEX - Google Patents

METHODS AND COMPOSITIONS FOR SUPPRESSING AN IMMUNE RESPONSE USING CLASS II PEPTIDES OF THE MAJOR HISTOCOMPATIBILITY COMPLEX

Info

Publication number
EP0914041A4
EP0914041A4 EP96933201A EP96933201A EP0914041A4 EP 0914041 A4 EP0914041 A4 EP 0914041A4 EP 96933201 A EP96933201 A EP 96933201A EP 96933201 A EP96933201 A EP 96933201A EP 0914041 A4 EP0914041 A4 EP 0914041A4
Authority
EP
European Patent Office
Prior art keywords
mhc
peptides
suppressing
class
compositions
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP96933201A
Other languages
German (de)
English (en)
French (fr)
Other versions
EP0914041A1 (en
Inventor
Mohamed H Sayegh
Barbara T Murphy
Charles B Carpenter
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Autoimmune Inc
Original Assignee
Autoimmune Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Autoimmune Inc filed Critical Autoimmune Inc
Publication of EP0914041A1 publication Critical patent/EP0914041A1/en
Publication of EP0914041A4 publication Critical patent/EP0914041A4/en
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70503—Immunoglobulin superfamily
    • C07K14/70539—MHC-molecules, e.g. HLA-molecules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Toxicology (AREA)
  • Cell Biology (AREA)
  • Genetics & Genomics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Transplantation (AREA)
  • Epidemiology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
EP96933201A 1995-09-21 1996-09-23 METHODS AND COMPOSITIONS FOR SUPPRESSING AN IMMUNE RESPONSE USING CLASS II PEPTIDES OF THE MAJOR HISTOCOMPATIBILITY COMPLEX Withdrawn EP0914041A4 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US411795P 1995-09-21 1995-09-21
US604117 1995-09-21
PCT/US1996/015662 WO1997010711A1 (en) 1995-09-21 1996-09-23 Methods and compositions for suppressing an immune response using major histocompatibility complex (mhc) class ii peptides

Publications (2)

Publication Number Publication Date
EP0914041A1 EP0914041A1 (en) 1999-05-12
EP0914041A4 true EP0914041A4 (en) 2000-06-28

Family

ID=21709234

Family Applications (1)

Application Number Title Priority Date Filing Date
EP96933201A Withdrawn EP0914041A4 (en) 1995-09-21 1996-09-23 METHODS AND COMPOSITIONS FOR SUPPRESSING AN IMMUNE RESPONSE USING CLASS II PEPTIDES OF THE MAJOR HISTOCOMPATIBILITY COMPLEX

Country Status (10)

Country Link
EP (1) EP0914041A4 (hu)
JP (1) JPH11513377A (hu)
KR (1) KR19990063637A (hu)
AU (1) AU7202596A (hu)
BR (1) BR9610625A (hu)
CA (1) CA2230119A1 (hu)
HU (1) HUP9901795A2 (hu)
IL (1) IL123759A0 (hu)
NO (1) NO981201D0 (hu)
WO (1) WO1997010711A1 (hu)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7247438B1 (en) 1997-02-18 2007-07-24 Dana-Farber Cancer Institute Methods of identifying agents which enhance caspase activity
JP2014133703A (ja) * 2011-03-30 2014-07-24 Clio Inc 生体組織から単離できるｓｓｅａ−３陽性の多能性幹細胞を含む他家移植用細胞治療用組成物

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1994004557A1 (en) * 1992-08-11 1994-03-03 President And Fellows Of Harvard College Immunomodulatory peptides

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1994004557A1 (en) * 1992-08-11 1994-03-03 President And Fellows Of Harvard College Immunomodulatory peptides

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
BENICHOU, GILLES ET AL.: "IMMUNOGENICITY AND TOLEROGENICITY OF SELF-MAJOR HISTOCOMPATIBILITY COMPLEX PEPTIDES", J EXP MED (1990) 172(5) 1341-6, XP000906710 *
LI, WAN FEN ET AL.: "MODULATION OF CLASS II RESTRICTED T CELL RESPONSES BY PEPTIDES DERIVED FROM SELF CLASS II MOLECULE", EUR J IMMUNOL (1992) 22(10) 2527-31, XP000892199 *
ROSLONIEC, EDWARD F. ET AL.: "MHC CLASS II-DERIVED PEPTIDES CAN BIND TO CLASS II MOLECULES INCLUDING SELF MOLECULES AND PREVENT ANTIGEN PRESENTATION", J EXP MED (1990) 171(5) 1419-30, XP000892195 *
See also references of WO9710711A1 *

Also Published As

Publication number Publication date
HUP9901795A2 (hu) 1999-09-28
CA2230119A1 (en) 1997-03-27
NO981201L (no) 1998-03-17
KR19990063637A (ko) 1999-07-26
BR9610625A (pt) 1999-03-16
WO1997010711A1 (en) 1997-03-27
IL123759A0 (en) 1998-10-30
AU7202596A (en) 1997-04-09
NO981201D0 (no) 1998-03-17
EP0914041A1 (en) 1999-05-12
JPH11513377A (ja) 1999-11-16

Similar Documents

Publication Publication Date Title
EP0560385A3 (en) Inter-hierarchy synchronizing system and an lsi using the same system
IL118004A (en) Vaccine compositions comprising an antigen saponin and a sterol
AU6096496A (en) Allogeneic and xenogeneic transplantation
ZA964733B (en) Ob protein compositions and methods
GB9620111D0 (en) Method and system for providing telephone number portability
EP0917689A4 (en) METHOD AND SYSTEM FOR VIRTUAL KINEMATOGRAPHY
IL117249A0 (en) Vaccine compositions
HUP9901546A3 (en) Helicobacter pylori antigens and vaccine compositions
AU5442794A (en) Simulation device and system
AU6095596A (en) Compositions and methods for improving autologous fat grafting
HK1029742A1 (en) Rapid release encapsulated bioactive agents for inducing or potentiating an immune response and methods of using thereof.
ZA9710725B (en) Antigen-specific IGG detection
AU9024991A (en) System and devices for time delay 3d
ZA985460B (en) Methods for inducing an immune response
AU7237496A (en) Methods and compositions comprising single chain recombinant antibodies
EP0418980A3 (en) System for combining independently clocked simulators
IL145891A0 (en) Methods and compositions for modulating an immune response
GB9322794D0 (en) Silicone release compositions
GB9706340D0 (en) Device for interconnection of two objects
EP0876157A4 (en) METHODS AND COMPOSITIONS FOR PASSIVE IMMUNOTHERAPY
AU1614799A (en) Virtual reality system and method
AU2273397A (en) Methods and compositions for modulating an immune response
ZA966801B (en) Antigenic preparations
AU4236097A (en) Mhc peptides and methods of use
IL123759A0 (en) Methods and compositions for suppressing an immune response using major histocompatibility complex (MHC) class II peptides

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 19980319

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE CH DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE

A4 Supplementary search report drawn up and despatched

Effective date: 20000511

AK Designated contracting states

Kind code of ref document: A4

Designated state(s): AT BE CH DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE

RAP1 Party data changed (applicant data changed or rights of an application transferred)

Owner name: AUTOIMMUNE, INC.

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20020403